About us

Exomnis Biotech is a Maastricht based start-up company, operating at the intersection of microbiology, engineering and immunology. As a spin-off from Maastricht University, taking advantage of more than 100 years combined experience, we have developed engineered commensal bacteria as “living medicines” with a first focus on immuno-therapeutics for cancer treatments.

Immunotherapy is proven to be a very effective cancer treatment option for selected patients and selected cancers. The therapeutics enhance the proprietary human immune system to target and
destroy cancer cells and/or attack the tumour defence system. However, hypoxic and necrotic cancer cells, present in nearly 90% of all solid tumours, may preclude the therapeutics from reaching the tumour cells.